Pathological complete remission of pulmonary epithelioid hemangioendothelioma: a case report and literature review.
[BACKGROUND] This study aims to report a case of pulmonary epithelioid hemangioendothelioma (PEH) achieving pathological complete remission following neoadjuvant treatment, thereby enhancing clinical
APA
Feng X, Chen F, et al. (2026). Pathological complete remission of pulmonary epithelioid hemangioendothelioma: a case report and literature review.. Journal of cardiothoracic surgery, 21(1). https://doi.org/10.1186/s13019-026-03846-y
MLA
Feng X, et al.. "Pathological complete remission of pulmonary epithelioid hemangioendothelioma: a case report and literature review.." Journal of cardiothoracic surgery, vol. 21, no. 1, 2026.
PMID
41680809
Abstract
[BACKGROUND] This study aims to report a case of pulmonary epithelioid hemangioendothelioma (PEH) achieving pathological complete remission following neoadjuvant treatment, thereby enhancing clinical understanding of this rare disease and providing valuable treatment insights.
[CASE PRESENTATION] The patient's imaging examination revealed a single large tumor on one side of the lung with lymph node metastasis. After treatment with albumin paclitaxel + carboplatin + bevacizumab, the tumor disappeared from the imaging findings, and postoperative pathology confirmed that the patient achieved pathological complete remission.
[CONCLUSION] PEH is rare in clinical practice and is a type of malignant tumor without characteristic clinical manifestations, and the diagnosis relies on pathological and immunohistochemical examinations. Single or few lesions can be treated surgically, whereas those that cannot undergo surgery can be treated with chemotherapy and targeted therapy.
[CASE PRESENTATION] The patient's imaging examination revealed a single large tumor on one side of the lung with lymph node metastasis. After treatment with albumin paclitaxel + carboplatin + bevacizumab, the tumor disappeared from the imaging findings, and postoperative pathology confirmed that the patient achieved pathological complete remission.
[CONCLUSION] PEH is rare in clinical practice and is a type of malignant tumor without characteristic clinical manifestations, and the diagnosis relies on pathological and immunohistochemical examinations. Single or few lesions can be treated surgically, whereas those that cannot undergo surgery can be treated with chemotherapy and targeted therapy.
MeSH Terms
Humans; Hemangioendothelioma, Epithelioid; Lung Neoplasms; Remission Induction; Male; Middle Aged; Female; Paclitaxel; Tomography, X-Ray Computed
같은 제1저자의 인용 많은 논문 (5)
- Hypoxia Alleviation-Potentiated Chemotherapy Enhances Anti-PD-L1 Treatment for Triple-Negative Breast Cancer via Improving Tumor Immunogenicity and Inhibiting STAT3 Activation.
- Translational advances in gastric cancer: integrating biomarkers, novel therapies, and microenvironment remodeling in 2025.
- Comparative analysis of the diagnostic value of dynamic contrast-enhanced magnetic resonance imaging kinetic heterogeneity and apparent diffusion coefficient for grading invasive breast cancer.
- Deep learning-based multimodal pathogenomics integration for precision cancer prognosis.
- Case Report: A rare case of breast leiomyoma with literature review.